Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
NEOG Neogen Corp
- Stocks
- Healthcare
- NASDAQ: NEOG
Price (delayed)
$6.5
Market cap
$1.41B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.23
Enterprise value
$2.18B
NEOGEN Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural
Highlights
Neogen's equity has decreased by 15% YoY
The gross profit is down by 7% YoY
Key stats
What are the main financial stats of NEOG
Market
Valuations
Earnings
Shares outstanding
217.04M
Market cap
$1.41B
Enterprise value
$2.18B
Price to earnings (P/E)
N/A
Price to book (P/B)
0.53
Price to sales (P/S)
1.56
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.4
Revenue
$906M
Gross profit
$442M
Operating income
-$436.77M
Net income
-$485.26M
EBIT
-$435.19M
EBITDA
-$312.6M
Free cash flow
-$39.35M
Per share
Balance sheet
Liquidity
EPS
-$2.23
EPS diluted
-$2.23
Free cash flow per share
-$0.18
Book value per share
$12.26
Revenue per share
$4.17
TBVPS
$4.26
Total assets
$4.04B
Total liabilities
$1.38B
Debt
$893.11M
Equity
$2.66B
Working capital
$410.51M
Debt to equity
0.34
Current ratio
3.91
Quick ratio
2.04
Net debt/EBITDA
-2.45
Margins
Efficiency
Dividend
EBITDA margin
-34.5%
Gross margin
48.8%
Net margin
-53.6%
Operating margin
-48.2%
Return on assets
-11.3%
Return on equity
-16.7%
Return on invested capital
-28.7%
Return on capital employed
-11.2%
Return on sales
-48%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NEOG stock price
How has the Neogen stock price performed over time
Intraday
8.88%
1 week
15.25%
1 month
16.49%
1 year
-47.28%
YTD
-46.46%
QTD
-25.03%
Financial performance
How have Neogen's revenue and profit performed over time
Revenue
$906M
Gross profit
$442M
Operating income
-$436.77M
Net income
-$485.26M
Gross margin
48.8%
Net margin
-53.6%
The gross profit is down by 7% YoY
The gross margin is down by 4.3% year-on-year
The net margin is down by 2.9% since the previous quarter
The revenue has contracted by 2.5% YoY
Price vs fundamentals
How does NEOG's price correlate with its fundamentals
Growth
What is Neogen's growth rate over time
Valuation
What is Neogen stock price valuation
P/E
N/A
P/B
0.53
P/S
1.56
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.4
The P/B is 82% less than the 5-year quarterly average of 2.9 and 47% less than the last 4 quarters average of 1.0
Neogen's equity has decreased by 15% YoY
The price to sales (P/S) is 75% lower than the 5-year quarterly average of 6.2 and 51% lower than the last 4 quarters average of 3.2
The revenue has contracted by 2.5% YoY
Efficiency
How efficient is Neogen business performance
Neogen's return on equity has decreased by 6% QoQ
The ROA is down by 4.6% since the previous quarter
Dividends
What is NEOG's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NEOG.
Financial health
How did Neogen financials performed over time
The total assets is 193% more than the total liabilities
The total assets has contracted by 12% YoY
The quick ratio is down by 6% year-on-year
The debt is 66% smaller than the equity
The company's debt to equity rose by 21% YoY and by 3% QoQ
Neogen's equity has decreased by 15% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.